Steris PLC (STE) News
Filter STE News Items
STE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
STE News Highlights
- For STE, its 30 day story count is now at 2.
- Over the past 7 days, the trend for STE's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SAFE are the most mentioned tickers in articles about STE.
Latest STE News From Around the Web
Below are the latest news stories about STERIS PLC that investors may wish to consider to help them evaluate STE as an investment opportunity.
2 Top Dividend Stocks to Buy and Hold for 2023 and BeyondWith that in mind, let's look at two attractive dividend stocks that might not yield enough to make it past your screener search. Steris (NYSE: STE) sells to hospitals and laboratories the sterilization equipment and consumable products, like sanitary wipes, that are needed to maintain a clean and safe working environment. Importantly, of its $4.6 billion in revenue for 2022, management estimates that a whopping 80% of its sales are recurring in nature, as individual hospitals and laboratories tend to buy the same volume of sterilization goods every quarter. |
Don't Buy STERIS plc (NYSE:STE) For Its Next Dividend Without Doing These ChecksIt looks like STERIS plc ( NYSE:STE ) is about to go ex-dividend in the next 4 days. The ex-dividend date is one... |
Why Steris Stock Was a Flop This WeekThe current earnings season brought some harsh weather to shareholders in Steris (NYSE: STE). The healthcare company unveiled its latest set of quarterly figures on Wednesday and was punished for it, as the stock traded down by almost 12% over the trading week, according to data from S&P Global Market Intelligence. For the third quarter of Steris' fiscal 2023, the company had $1.22 billion in revenue. |
STERIS (STE) Q3 Earnings Miss Estimates, Margins Down Y/YNegative foreign currency and the impact of increased supply chain and inflationary costs hurt STERIS (STE) revenues in the fiscal third quarter. |
Steris (STE) Lags Q3 Earnings and Revenue EstimatesSteris (STE) delivered earnings and revenue surprises of -9.01% and 4.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
STERIS Announces Financial Results for Fiscal 2023 Third QuarterAs reported revenue increased 1%; 7% constant currency organic revenue growthAs reported earnings per share of $1.24; adjusted EPS of $2.02Updated outlook provided DUBLIN, IRELAND, Feb. 08, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Revenue as reported for the quarter increased 1% to $1.22 billion compared with $1.21 billion in the third quarter of fiscal 2022. Constant c |
Hologic (HOLX) Q1 Earnings and Revenues Beat EstimatesHologic (HOLX) delivered earnings and revenue surprises of 18.89% and 9.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
STERIS Declares $0.47 per share DividendDUBLIN, IRELAND, Feb. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable March 23, 2023 to shareholders of record at the close of business on February 24, 2023. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by |
STERIS (STE) to Report Q3 Earnings: What's in the Cards?STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend. |
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter |